Children With Autism Clinical Trial
— CAACOfficial title:
Computer Assisted Autism Care (CAAC)
| Verified date | March 2015 |
| Source | Indiana University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
The investigators hypothesize that children seen in a clinic that uses a compute based system known as CHICA, which reminds pediatricians to screen at defined time point for autism, will be screened more consistently for autism and receive more timely diagnostic a treatment services.
| Status | Completed |
| Enrollment | 368 |
| Est. completion date | July 2014 |
| Est. primary completion date | July 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 17 Months to 4 Years |
| Eligibility |
Inclusion Criteria: - Previously healthy children receiving routine care in one of four clinics in Indianapolis who participate in this study. Exclusion Criteria: - Previously known autism spectrum disorders or other causes of developmental delay |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening
| Country | Name | City | State |
|---|---|---|---|
| United States | Wishard (Eskenazi) Healthcare clinics | Indianapolis | Indiana |
| Lead Sponsor | Collaborator |
|---|---|
| Indiana University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Structure autism screening instrument administered | Physicians are reminded by the computer system to screen children under 3 years of age for autism with a structured screening instrument. Chart abstraction is used to document whether or not the screening occurred. | Up to 4 years | No |
| Secondary | Are appropriate diagnostic studies conducted among children who screen positive for autism. | Among children who a suspected of having autism, chart abstraction and interviews are done to determine if the child received appropriate diagnostic and studies. | Up to 4 years | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03253081 -
Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response
|
N/A | |
| Not yet recruiting |
NCT04246398 -
FMT in Children With Autism and Gastrointestinal Symptoms
|
N/A |